Theravance Biopharma
TBPH
TBPH
122 hedge funds and large institutions have $648M invested in Theravance Biopharma in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 112 → 122 (+10)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.54% less ownership
Funds ownership: 84.35% → 83.82% (-0.54%)
Holders
122
Holding in Top 10
3
Calls
$9.48M
Puts
$4.19M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$7.06M | |
| 3 | +$6.62M | |
| 4 |
Millennium Management
New York
|
+$6.6M |
| 5 |
NM
Newtyn Management
New York
|
+$4.64M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$12.7M | |
| 3 | -$5.46M | |
| 4 |
MAP
Madison Avenue Partners
New York
|
-$2.61M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$2.29M |